Clinical Evaluation of Minimized Extracorporeal Circulation in High-risk Coronary Revascularization: Impact on Air Handling, Inflammation, Hemodilution and Myocardial Function
Overview
Affiliations
Objective: We examined intraoperative microembolic signals (GME), inflammatory response, hemolysis, perioperative regional cerebral oxygen saturation (rSO(2)), myocardial protection and desorbed protein amount on oxygenator fibers in high-risk patients undergoing coronary revascularization (CABG) with minimized and conventional cardiopulmonary bypass (CPB).
Methods: Over a ten-month period, 40 Euroscore 6+ patients undergoing CABG were prospectively randomized to one of the two perfusion protocols (N=20): Group 1: minimized extracorporeal circuits (Mini-CPB) (ROCsafe MPC, Terumo, Ann Arbor, MI, USA) and Group 2: conventional extracorporeal circuits (CECC) (Capiox SX18, Terumo, USA). Serum creatinine kinase-MB (CKMB), free hemoglobin, interleukin-6 (IL-6) and C3a levels were measured. Blood samples were collected at T1: following induction of anesthesia; T2: thromboelastography control; T3:15 min after commencement of CPB; T4: before cessation of CPB; T5: 15 min after protamine reversal and T6: ICU.
Results: Serum IL-6 levels were significantly lower in the Mini-CPB group at T4 and T5 and C3a levels were significantly less in the Mini-CPB group at T3, T4 and T5 vs. CECC (p<0.01). CKMB levels in coronary sinus blood demonstrated well preserved myocardium in the Mini-CPB group. Percentage expression of neutrophil CD11b/CD18 levels were significantly lower in the Mini-CPB group at T4 and T5 (p<0.05). There were no significant differences in air handling characteristics or free plasma hemoglobin levels in either circuit. rSO(2) measurements were significantly better at T3 and T4 in the Mini-CPB vs. CECC (p<0.05) and always higher in the Mini-CPB during follow-up. Blood protein adsorption analysis of oxygenator membranes demonstrated a significantly increased amount of microalbumin on CECC fibers (p<0.05).
Conclusion: Mini-CPB provided a comfort and safety level similar to conventional control via satisfactory air handling, attenuated inflammatory response and hemodilution, with a better clinical outcome in patients undergoing high-risk CABG.
Abbasciano R, Tomassini S, Roman M, Rizzello A, Pathak S, Ramzi J Cochrane Database Syst Rev. 2023; 10:CD013584.
PMID: 37873947 PMC: 10594589. DOI: 10.1002/14651858.CD013584.pub2.
Hemolysis and cardiopulmonary bypass: meta-analysis and systematic review of contributing factors.
Bhirowo Y, Raksawardana Y, Setianto B, Sudadi S, Tandean T, Zaharo A J Cardiothorac Surg. 2023; 18(1):291.
PMID: 37833747 PMC: 10571250. DOI: 10.1186/s13019-023-02406-y.
Conventional versus miniaturized cardiopulmonary bypass: A systematic review and meta-analysis.
Cheng T, Barve R, Cheng Y, Ravendren A, Ahmed A, Toh S JTCVS Open. 2022; 8:418-441.
PMID: 36004169 PMC: 9390465. DOI: 10.1016/j.xjon.2021.09.037.
Sardu C, Massetti M, Testa N, Di Martino L, Castellano G, Turriziani F Front Pharmacol. 2021; 12:777083.
PMID: 34867407 PMC: 8634684. DOI: 10.3389/fphar.2021.777083.
Gunaydin S, Ozisik K, Gunertem O, Budak A, Babaroglu S, Tekeli A J Extra Corpor Technol. 2020; 52(2):90-95.
PMID: 32669734 PMC: 7332164. DOI: 10.1182/ject-2000015.